Qingshan Likang

I. Introduction to Chengdu Qingshan Likang Pharmaceutical Co., Ltd.
Backed by the strong resource platforms of Kelun Pharmaceutical and West China Hospital of Sichuan University;
A high-growth pharmaceutical enterprise with over 20 years of sound operations and continuous growth, generating annual profits in the hundreds of millions;
A professional service provider in the field of blood purification technology.
II. Product Advantages
1. The patented product "Hemofiltration Replacement Base Solution" has made significant contributions in numerous major disaster rescues;
2. Peritoneal Dialysis Solution has gained widespread market recognition, with its market share consistently ranking among the top domestic brands;
3. Successfully commercialized the national 863 project Xierfu, which has global innovative value, and obtained Class III medical device approval for decellularized biological amniotic membrane.
III. Innovation Platforms

1. National High-tech Enterprise, Sichuan Provincial Enterprise Technology Center;
2. National and Local Joint Engineering Laboratory for Blood Purification Product Preparation Technology;
3. Co-built a research, learning, production, and application integrated scientific research and technology innovation platform with universities and research institutions;
4. Nearly 100 authorized patents, and led the formulation of over 10 national and industry standards.
IV. Career Development Platform
1. Talent philosophy: Retain talent through career opportunities, emotional connection, and competitive compensation;
2. Career development: Dual career paths, offering both vertical & horizontal development opportunities;
3. Training/Development:
● Learning opportunities through platforms such as Kelun Pharmaceutical, West China Hospital, and the State Key Laboratory of Biotherapy of Sichuan University;
● New employee training, customized training, advanced training, specialized training, talent development, and elite development programs.